Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

NCT01986426

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations: Jules Bordet Institute Brussels, Belgium

Cliniques Universitaires St-Luc, Service d'oncologie médicale Brussels, Belgium

Institut Curie Paris, France

Institute Gustave Roussy Paris, France

View all 14 locations

View Trial Details

Completed

A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma

NCT02272855

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Clinical Site San Francisco, California, United States

Clinical Site Atlanta, Georgia, United States

Clinical Site Portland, Oregon, United States

Clinical Site Bethlehem, Pennsylvania, United States

View Trial Details

Completed

Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer

NCT01215500

Conditions: Cancer, Carcinoma, Melanoma, +15 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma

NCT01608594

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

NCT00243061

Conditions: Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, +25 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)

NCT02155322

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Trial of Surgical Excision Margins in Thick Primary Melanoma - 2

NCT03638492

Conditions: Margins of Excision, Melanoma, Morphological and Microscopic Findings, +14 more
Locations: Not specified

View Trial Details

Completed

Study of Ipilimumab in the Immune System

NCT01715077

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

COPARIME: Pilot Study of a Target Detection of Malignant Melanoma

NCT01610531

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: University Hospital Nantes, France

View Trial Details

Completed

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

NCT01673854

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Beverly Hills Cancer Center Beverly Hills, California, United States

Baptist Cancer Institute Jacksonville, Florida, United States

Orlando Health, Inc Orlando, Florida, United States

Winship Cancer Institute Atlanta, Georgia, United States

View all 14 locations

View Trial Details